Clinical Trial Update: 28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing paliperidone palmitate injectable to oral risperidone in adults with schizophrenia diagnosed within the past five years was terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• INVEGA SUSTENNA (PALIPERIDONE PALMITATE)
• Risperdal (risperidone)

Snippet

Sponsor: Ortho-McNeil Janssen Scientific Affairs, LLC | Conditions: Schizophrenia | Phase 4 | Status: TERMINATED | Results posted: 2012-07-16